Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nephros ( (NEPH) ) has provided an announcement.
On February 26, 2025, Nephros, Inc. amended the employment terms of its Chief Financial Officer, Judith Krandel. The amendment grants Ms. Krandel two 10-year stock options under the company’s 2024 Equity Incentive Plan, with specific vesting conditions tied to her continued employment and the company’s strategic transactions. Additionally, her annual performance bonus target is increased to 30% of her base salary. This amendment could potentially strengthen the company’s leadership stability and incentivize growth-oriented strategies.
More about Nephros
YTD Price Performance: 3.42%
Average Trading Volume: 12,602
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $15.92M
See more insights into NEPH stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue